Form 4: Twist Bioscience COO Patrick John Finn Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Patrick John Finn, President and COO of Twist Bioscience, sold 2,174 shares of common stock on April 23, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On April 23, 2024, Patrick John Finn, the President and COO of Twist Bioscience, sold 2,174 shares of the company's common stock.
- The sale was executed at a price of $30.121 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Finn directly owns 176,206 shares of Twist Bioscience common stock.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (selling shares to cover taxes). It's neutral in tone and doesn't indicate any significant positive or negative developments for the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 04/23/2024 | Date of stock sale transaction |
| 04/25/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.